259 related articles for article (PubMed ID: 10843744)
21. Alpha-fetoprotein serum concentration in different stages of liver cirrhosis.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 1997; 42(1):75-80. PubMed ID: 9581466
[TBL] [Abstract][Full Text] [Related]
22. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor-beta1 as a surrogate marker of hepatic dysfunction in chronic liver diseases.
Flisiak R; Prokopowicz D
Clin Chem Lab Med; 2000 Nov; 38(11):1129-31. PubMed ID: 11156342
[TBL] [Abstract][Full Text] [Related]
24. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
[TBL] [Abstract][Full Text] [Related]
25. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
[TBL] [Abstract][Full Text] [Related]
26. Single dose of anti-transforming growth factor-beta1 monoclonal antibody enhances liver regeneration after partial hepatectomy in biliary-obstructed rats.
Deneme MA; Ok E; Akcan A; Akyildiz H; Soyuer I; Muhtaroglu S
J Surg Res; 2006 Dec; 136(2):280-7. PubMed ID: 17046790
[TBL] [Abstract][Full Text] [Related]
27. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
28. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of matrix metalloproteinase on hepatic transforming growth factor beta1 and caspase-3 activation in hemorrhage.
Maitra SR; Bhaduri S; El-Maghrabi MR; Shapiro MJ
Acad Emerg Med; 2005 Sep; 12(9):797-803. PubMed ID: 16141011
[TBL] [Abstract][Full Text] [Related]
30. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
[TBL] [Abstract][Full Text] [Related]
31. [Changes in transforming growth factor beta 1 mRNA and its clinical value in patients with schistosomal liver fibrosis].
Chen F; Cai W; Chen Z; Liu R
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(3):140-2. PubMed ID: 12563829
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
[TBL] [Abstract][Full Text] [Related]
33. [Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis].
Hartleb M; Kirstetter P; Moreau R; Soupison T; Pussard E; Hadengue A; Sogni P; Gaudin C; Lebrec D
Gastroenterol Clin Biol; 1994; 18(5):407-12. PubMed ID: 7813855
[TBL] [Abstract][Full Text] [Related]
34. [The plasma levels of transforming growth factor beta1 and the protein expressions of alpha-SMA, urokinase plasminogen activator and plasminogen activator inhibitor-1 in liver of patients with different grades of hepatic fibrosis].
Wu XR; Lv MH; Wang Q; Shi SS; Guo WD
Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):400-2. PubMed ID: 15268802
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
[TBL] [Abstract][Full Text] [Related]
36. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
Breitkopf K; Lahme B; Tag CG; Gressner AM
Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
[TBL] [Abstract][Full Text] [Related]
37. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
[TBL] [Abstract][Full Text] [Related]
38. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R
Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387
[TBL] [Abstract][Full Text] [Related]
39. Plasma transforming growth factor-beta(1) in acute viral hepatitis.
Flisiak R; Prokopowicz D; Jaroszewicz J; Flisiak I
Med Sci Monit; 2005 Jun; 11(6):CR304-308. PubMed ID: 15917723
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor-beta1 in plasma and liver of children with liver disease.
Rosensweig JN; Omori M; Page K; Potter CJ; Perlman EJ; Thorgeirsson SS; Schwarz KB
Pediatr Res; 1998 Sep; 44(3):402-9. PubMed ID: 9727721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
